Modular, Distributed, Flexible, Redundant, Patient-Specific Intra-Venous (IV) Automation Robot for Non-Hazardous Drug Preparation, Compounding, and Dispensing in Central Pharmacy Locations, Satellite Pharmacies, and Even
Patient Care Workplaces
BOZEN, SUDTIROL, Italy, June 7 /PRNewswire/ -- Health Robotics, the worldwide leader in the robotic automation of patient-specific IV Admixtures today announced IV Station (TM Pending), a new IV automation solution that complements CytoCare(TM), the company's award-winning and world-leading patient-specific chemotherapy IV robot.
IV Station (TM Pending) is aimed at helping global health care providers deliver rapid, cost-effective, and safer IV doses to their patients by addressing medication errors, sterility, accuracy, and waste problems in the preparation, compounding, and dispensing of IV Admixtures.
"While many companies have recognized the life-critical importance of IV safety, all patient-specific automation solutions up until now have focused on the prescription and administration steps of the medication delivery process with products such as Electronic Prescription and Smart Infusion Pumps," said Werner Rainer, CEO of Health Robotics.
IV Station (TM Pending) is the first patient-specific automation solution in the world that focuses on the preparation and compounding step of the life-critical process of IV Admixtures, where medication errors are arguably more critical given the inherent difficulty in their detection.
Beyond its patient safety benefits, IV Station (TM Pending) will
address the waste problems of the current pharmacy process of Batch IVs
[IVs that are not tailored to a specific patient clinical condition and
therapy], whether these Batch IVs are processed by Batch IV automation
companies or by hospitals that compound manually in Batch mode. IV Station
(TM Pending) offers global health care providers unique features and
benefits by pi
|SOURCE Health Robotics|
Copyright©2008 PR Newswire.
All rights reserved